4th Quarter - Report
CAMERON COMPANIES for FOX CHASE CANCER CENTER
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T. Reviewed HR 3235, Access to Genetic Counselor Services Act and HR 1948, Lymphedema Treatment Act for potential support.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER MOYER | — |
| ROBERT TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.